AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 at Upcoming American Academy of Ophthalmology 2021 Annual Meeting
Stock Information for Applied Genetic Technologies Corporation
Loading
Please wait while we load your information from QuoteMedia.